Your browser doesn't support javascript.
loading
Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC).
Mahamat-Saleh, Yahya; Al-Rahmoun, Marie; Severi, Gianluca; Ghiasvand, Reza; Veierod, Marit B; Caini, Saverio; Palli, Domenico; Botteri, Edoardo; Sacerdote, Carlotta; Ricceri, Fulvio; Lukic, Marko; Sánchez, Maria J; Pala, Valeria; Tumino, Rosario; Chiodini, Paolo; Amiano, Pilar; Colorado-Yohar, Sandra; Chirlaque, María-Dolores; Ardanaz, Eva; Bonet, Catalina; Katzke, Verena; Kaaks, Rudolf; Schulze, Matthias B; Overvad, Kim; Dahm, Christina C; Antoniussen, Christian S; Tjønneland, Anne; Kyrø, Cecilie; Bueno-de-Mesquita, Bas; Manjer, Jonas; Jansson, Malin; Esberg, Anders; Mori, Nagisa; Ferrari, Pietro; Weiderpass, Elisabete; Boutron-Ruault, Marie-Christine; Kvaskoff, Marina.
  • Mahamat-Saleh Y; Paris-Saclay University, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, Villejuif, France.
  • Al-Rahmoun M; Paris-Saclay University, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, Villejuif, France.
  • Severi G; Paris-Saclay University, UVSQ, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP, Villejuif, France.
  • Ghiasvand R; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
  • Veierod MB; Department of Research, Cancer Registry of Norway, Oslo University Hospital, Oslo, Norway.
  • Caini S; Oslo Centre for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Palli D; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Botteri E; Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • Sacerdote C; Department of Research, Cancer Registry of Norway, Oslo University Hospital, Oslo, Norway.
  • Ricceri F; Section for Colorectal Cancer Screening, Cancer Registry of Norway, Oslo University Hospital, Oslo, Norway.
  • Lukic M; Piedmont Reference Centre for Epidemiology and Cancer Prevention (CPO Piemonte), Turin, Italy.
  • Sánchez MJ; Epidemiology Unit, ASL TO3 Piedmont Region, Grugliasco, Italy.
  • Pala V; Faculty of Health Sciences, Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Norway.
  • Tumino R; Escuela Andaluza de Salud Pública (EASP), Granada, Spain.
  • Chiodini P; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Amiano P; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Colorado-Yohar S; Department of Preventive Medicine and Public Health, University of Granada, Granada, Spain.
  • Chirlaque MD; Epidemiology and Prevention Unit Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Ardanaz E; Hyblean Association for Epidemiological Research AIRE-ONLUS, Ragusa, Italy.
  • Bonet C; Dipartimento di Salute Mentale e Fisica e Medicina Preventiva, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
  • Katzke V; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Kaaks R; Ministry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain.
  • Schulze MB; Biodonostia Health Research Institute, Epidemiology of Chronic and Communicable Diseases Group, San Sebastián, Spain.
  • Overvad K; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Dahm CC; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
  • Antoniussen CS; Research Group on Demography and Health, National Faculty of Public Health, University of Antioquia, Medellín, Colombia.
  • Tjønneland A; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Kyrø C; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
  • Bueno-de-Mesquita B; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Manjer J; Navarra Public Health Institute, Pamplona, Spain.
  • Jansson M; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Esberg A; Unit of Nutrition and Cancer, Catalan Institute of Oncology-ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-(IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
  • Mori N; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ferrari P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weiderpass E; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Boutron-Ruault MC; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
  • Kvaskoff M; Department of Public Health, Aarhus University, Aarhus C, Denmark.
Int J Cancer ; 152(3): 348-362, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36053839
Experimental evidence suggests that alcohol induces cutaneous carcinogenesis, yet epidemiological studies on the link between alcohol intake and skin cancer have been inconsistent. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort initiated in 1992 in 10 European countries. Alcohol intake at baseline and average lifetime alcohol intake were assessed using validated country-specific dietary and lifestyle questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in Cox models. A total of 14 037 skin cancer cases (melanoma: n = 2457; basal-cell carcinoma (BCC): n = 8711; squamous-cell carcinoma (SCC): n = 1928; unknown: n = 941) were identified among 450 112 participants (average follow-up: 15 years). Baseline alcohol intake was positively associated with SCC (>15 vs 0.1-4.9 g/day: HR = 1.44, 95% CI = 1.17-1.77; Ptrend  = .001), BCC (HR = 1.12, 95% CI = 1.01-1.23; Ptrend  = .04), and melanoma risks in men (HR = 1.17, 95% CI = 0.95-1.44; Ptrend  = .17), while associations were more modest in women (SCC: HR = 1.09, 95% CI = 0.90-1.30; Ptrend  = .13; BCC: HR = 1.08, 95% CI = 1.00-1.17, Ptrend  = .03; melanoma: HR = 0.93, 95% CI = 0.80-1.08, Ptrend  = .13). Associations were similar for lifetime alcohol intake, with an attenuated linear trend. Lifetime liquor/spirit intake was positively associated with melanoma (fourth vs first quartile: HR = 1.47, 95% CI = 1.08-1.99; Ptrend  = .0009) and BCC risks in men (HR = 1.17, 95% CI = 1.04-1.31; Ptrend  = .14). Baseline and lifetime intakes of wine were associated with BCC risk (HR = 1.25 in men; HR = 1.11-1.12; in women). No statistically significant associations were found between beverage types and SCC risk. Intake of beer was not associated with skin cancer risk. Our study suggests positive relationships between alcohol intake and skin cancer risk, which may have important implications for the primary prevention of skin cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma Basocelular / Carcinoma de Células Escamosas / Melanoma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Carcinoma Basocelular / Carcinoma de Células Escamosas / Melanoma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2023 Tipo del documento: Article